Trends in Complications and Outcomes in Patients Aged 65 Years and Younger Undergoing Total Knee Arthroplasty: Data From the American Joint Replacement Registry

医学 生存曲线 共病 查尔森共病指数 关节置换术 外科 单变量分析 回顾性队列研究 人口
作者
Akash Shah,David Alexander Cieremans,James Slover,Ran Schwarzkopf,Morteza Meftah
出处
期刊:Journal of the American Academy of Orthopaedic Surgeons [Wolters Kluwer]
卷期号:6 (6)
标识
DOI:10.5435/jaaosglobal-d-22-00116
摘要

The purpose of this study was to identify common complications and the rates of readmission and revision in total knee arthroplasty (TKA) patients younger than 65 years.Using the American Joint Replacement Registry, we conducted a retrospective review of all TKAs done in patients aged 18 to 65 years from 2012 to 2020. Demographic factors such as age, sex, Charlson Comorbidity Index (CCI), and preoperative Veterans RAND 12-Item Health Survey Physical Component Summary (VR-12 PCS) scores were collected. We excluded patients older than 65 years and revision, oncologic, and nonelective cases. Primary outcomes included cumulative revision rate, 90-day readmission rate, and reason for revision. Univariate analysis and the Kaplan-Meier method were used.Six thousand one hundred seventy-nine patients were included. The average age was 58.8 years (SD 5.5 years), 61% were female, 82% were White, and 88% had a CCI of 0 (1 = 8% and ≥2 = 4%). The mean follow-up was 42.51 months. Seventy-four patients (1.2%) underwent revision. Sixty-nine patients (1.1%) were readmitted within 90 days. No factors assessed increased revision rates. Revision-free survivorship was 98.7% (95% CI 98.4 to 99.0) and 98.6% (95% CI 98.2 to 99.0) at 5 and 8 years, respectively. Infection (15%), aseptic loosening (14%), and instability (12%) were the most common indications for revision.TKA done in young and presumed active patients has excellent survivorship. Long-term follow-up is needed to assess survival trends in this growing population.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
香蕉觅云应助能干冰岚采纳,获得10
刚刚
1秒前
星辰大海应助Marksman497采纳,获得10
1秒前
李爱国应助婉君采纳,获得20
1秒前
1秒前
建建发布了新的文献求助10
2秒前
2秒前
共享精神应助boohey采纳,获得70
3秒前
陈琰发布了新的文献求助10
5秒前
suodeheng完成签到,获得积分20
5秒前
小葱头应助科研通管家采纳,获得10
6秒前
星辰大海应助科研通管家采纳,获得10
6秒前
科目三应助科研通管家采纳,获得10
6秒前
大模型应助科研通管家采纳,获得10
6秒前
Hello应助科研通管家采纳,获得10
6秒前
6秒前
夜雨声烦发布了新的文献求助30
6秒前
小马甲应助科研通管家采纳,获得10
6秒前
脑洞疼应助科研通管家采纳,获得10
6秒前
无极微光应助科研通管家采纳,获得20
6秒前
SciGPT应助科研通管家采纳,获得10
6秒前
lizishu应助科研通管家采纳,获得10
6秒前
大个应助科研通管家采纳,获得10
6秒前
NexusExplorer应助科研通管家采纳,获得10
7秒前
英俊的铭应助科研通管家采纳,获得10
7秒前
李健应助科研通管家采纳,获得10
7秒前
小葱头应助科研通管家采纳,获得10
7秒前
方芝婷发布了新的文献求助10
7秒前
FashionBoy应助科研通管家采纳,获得10
7秒前
天天快乐应助科研通管家采纳,获得10
7秒前
Akim应助科研通管家采纳,获得10
7秒前
隐形曼青应助科研通管家采纳,获得10
7秒前
gyh应助科研通管家采纳,获得10
7秒前
orixero应助科研通管家采纳,获得10
7秒前
我是老大应助科研通管家采纳,获得10
7秒前
沉默伟宸应助科研通管家采纳,获得10
7秒前
7秒前
7秒前
慕青应助科研通管家采纳,获得10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 2000
Digital Twins of Advanced Materials Processing 2000
晋绥日报合订本24册(影印本1986年)【1940年9月–1949年5月】 1000
Social Cognition: Understanding People and Events 1000
Polymorphism and polytypism in crystals 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6032705
求助须知:如何正确求助?哪些是违规求助? 7722753
关于积分的说明 16201263
捐赠科研通 5179362
什么是DOI,文献DOI怎么找? 2771782
邀请新用户注册赠送积分活动 1755051
关于科研通互助平台的介绍 1640057